Research / NVDA / Fundamental state Inspectable configuration
State dimensions Filing 0001045810-24-000264 General Corporate
Debt relative to revenue 6th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.debt_to_revenue
28.17% · OPTIONAL · VALID
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.25% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation 93th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
48.23% · OPTIONAL · VALID
Revenue growth 75th Own-history percentile · N=12
Evidence method Yoy · gp.fundamentals.revenue
122.40% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
22.22% · OPTIONAL · VALID
Gross margin 94th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.gross_margin
75.15% · CORE · VALID
Operating margin 94th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.operating_margin
62.06% · CORE · VALID
R&D intensity 0th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.29% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.84% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Oct 31, 2021 0/9 normalized Level 3 Jan 30, 2022 0/8 normalized Level 3 May 1, 2022 0/8 normalized Level 3 Jul 31, 2022 6/8 normalized Level 3 Oct 30, 2022 7/8 normalized Level 3 Jan 29, 2023 7/8 normalized Level 3 Apr 30, 2023 7/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Oct 29, 2023 8/8 normalized Level 3 Jan 28, 2024 8/9 normalized Level 3 Apr 28, 2024 8/9 normalized Level 3 Jul 28, 2024 8/9 normalized Level 3 Oct 27, 2024 8/9 normalized Level 3 Jan 26, 2025 9/9 normalized Level 3 Apr 27, 2025 9/9 normalized Level 3 Jul 27, 2025 9/9 normalized Level 3 Oct 26, 2025 9/9 normalized Level 3 Jan 25, 2026 9/9 normalized Level 3 Apr 26, 2026 9/9 normalized Level 3 Jul 26, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 37.28%
Current 28.17%
Delta -9.12% Capex Intensity Increased
Previous 1.42%
Current 3.25%
Delta 1.84% Cash Generation Decreased
Previous 58.92%
Current 48.23%
Delta -10.69% Growth Decreased
Previous 262.12%
Current 122.40%
Delta -139.72% Inventory Pressure Decreased
Previous 22.52%
Current 22.22%
Delta -0.30% Margin Decreased
Previous 78.35%
Current 75.15%
Delta -3.21% Profitability Decreased
Previous 64.92%
Current 62.06%
Delta -2.87% R And D Intensity Decreased
Previous 10.44%
Current 10.29%
Delta -0.16% Sbc Intensity Decreased
Previous 3.88%
Current 3.84%
Delta -0.04% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.